<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01847482</url>
  </required_header>
  <id_info>
    <org_study_id>COOL-ARREST JP</org_study_id>
    <nct_id>NCT01847482</nct_id>
  </id_info>
  <brief_title>Therapeutic Hypothermia With IntraVascular Temperature Management (IVTM) in Post-Cardiogenic Cardiac Arrest and Post-Return of Spontaneous Circulation Patients in Japan</brief_title>
  <official_title>COOL-ARREST JP: A Multicenter, Prospective, Single-arm Interventional Trial to Evaluate Therapeutic Hypothermia With IntraVascular Temperature Management (IVTM) in Post-Cardiogenic Cardiac Arrest and Post-Return of Spontaneous Circulation Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ZOLL Circulation, Inc., USA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Asahi Kasei Medical Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>ZOLL Circulation, Inc., USA</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A multicenter, single-arm, prospective, interventional trial to evaluate therapeutic
      hypothermia with intravascular temperature management (IVTM) in post-cardiogenic cardiac
      arrest, post-return of spontaneous circulation (ROSC) patients in Japan.

      The objective of this study is to verify that therapeutic hypothermia performed by
      intravascular cooling using the investigational device (IVTM) can control body temperature
      appropriately in post-cardiogenic cardiac arrest, post-ROSC patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Actual">January 19, 2016</completion_date>
  <primary_completion_date type="Actual">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Core temperature achievement ratio</measure>
    <time_frame>Baseline and 3 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cerebral Performance Category (CPC)</measure>
    <time_frame>Baseline and 14 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modified Rankin Scale (mRS)</measure>
    <time_frame>Baseline and 14 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in body temperature</measure>
    <time_frame>Baseline and 96 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cooling speed</measure>
    <time_frame>Baseline and 3 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety</measure>
    <time_frame>Baseline vs. 2 days</time_frame>
    <description>Incidence of adverse events at 2 days compared to baseline.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety</measure>
    <time_frame>Baseline vs. 14 days</time_frame>
    <description>Incidence of adverse events at 14 days compared to baseline.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">26</enrollment>
  <condition>Cardiac Arrest</condition>
  <arm_group>
    <arm_group_label>Therapeutic Hypothermia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ZOLL Intravascular Temperature Management System (IVTM)</intervention_name>
    <description>Induced therapeutic hypothermia post cardiac arrest</description>
    <arm_group_label>Therapeutic Hypothermia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Non-traumatic in-hospital or out-of-hospital cardiac arrest

          2. Unwitnessed cardiac arrest (Ventricular fibrillation), or witnessed cardiac arrest
             (ventricular fibrillation, pulseless electrical activity, asystole within 15 minutes
             following onset)

          3. Patient is at least 20 years of age and less than 80 years of age with consent is
             given

          4. In the judgement of an investigator or sub-investigator, the patient is unable to
             follow verbal instructions

          5. Therapeutic hypothermia using the investigational device can be initiated within six
             hours of Return of Spontaneous Circulation (ROSC)

          6. Written consent can be obtained from a legally acceptable representative

        Exclusion Criteria:

          1. Traumatic cardiac arrest (blunt trauma, penetrating trauma, burns, exsanguination,
             suffocation, smoke inhalation, near drowning, etc)

          2. Accidental hypothermia with core body temperature less than 35.0Â°C

          3. Pregnant or of child bearing potential

          4. Patient has given or indicated a Do Not Resuscitate (DNR) order

          5. Femoral venous access is contraindicated by previous surgey, medical history, anatomy
             or the like

          6. An inferior vena cava filter is in place

          7. Patient has severe bleeding (Pulmonary hemorrhage, gastrointestinal hemorrhage, etc.)

          8. Intracranial hemorrhage as confirmed by CT scanning

          9. Hemodynamic instability despite use of vasopressor agents and cardiac stimulants

         10. Heparin hypersensitivity

         11. Serious systemic infectious diseases (sepsis, etc.)

         12. Platelet count less than 30,000/mm3

         13. Serious hepatic dysfunction

         14. Serious renal impairment

         15. Using percutaneous cardiopulmonary support (PCPS)

         16. Using continuous hemodiafiltration (CHDF)

         17. Therapeutic hypothermia has been otherwise implemented between ROSC and the start of
             the study (excluding the rapid infusion of non-glucose-containing cold electrolyte
             fluid, or non-glucose-containing cold plasma volume expander)

         18. The patient's core body temperature cannot be monitored

         19. Currently participating in another clinical trial or has participated in another
             clinical trial within the past six months

         20. in the judgement of an investigator or sub-investigator, participation in this
             clinical trial is inappropriate for the patient
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yoichi Kato, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Asahi Kasei Medical Co., Ltd.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tsuyoshi Maekawa, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yamaguchi Grand Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kokura Memorial Hospital</name>
      <address>
        <city>Kitakyushu</city>
        <state>Fukuoka</state>
        <zip>802-8555</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sapporo Medical University Hospital</name>
      <address>
        <city>Sapporo</city>
        <state>Hokkaido</state>
        <zip>060-8543</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hyogo College of Medicine Hospital</name>
      <address>
        <city>Nishinomiya</city>
        <state>Hyogo</state>
        <zip>663-8501</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Iwate Medical University Hospital</name>
      <address>
        <city>Morioka</city>
        <state>Iwate</state>
        <zip>020-8505</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kagawa University School of Medicine</name>
      <address>
        <city>Miki</city>
        <state>Kagawa</state>
        <zip>761-0793</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nipponn Medical School Hospital</name>
      <address>
        <city>Bunkyo</city>
        <state>Tokyo</state>
        <zip>113-8603</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Surugadai Nihon University Hospital</name>
      <address>
        <city>Chiyoda</city>
        <state>Tokyo</state>
        <zip>101-8309</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yamaguchi University Hospital</name>
      <address>
        <city>Ube</city>
        <state>Yamaguchi</state>
        <zip>755-8505</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Hospital Organization Kumamoto Medical Center</name>
      <address>
        <city>Kumamoto</city>
        <zip>860-0008</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Osaka City General Hospital</name>
      <address>
        <city>Osaka</city>
        <zip>534-0021</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 11, 2013</study_first_submitted>
  <study_first_submitted_qc>May 1, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 6, 2013</study_first_posted>
  <last_update_submitted>May 30, 2017</last_update_submitted>
  <last_update_submitted_qc>May 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cardiac arrest</keyword>
  <keyword>Return of Spontaneous Circulation (ROSC)</keyword>
  <keyword>IntraVascular Temperature Management (IVTM)</keyword>
  <keyword>Therapeutic Hypothermia</keyword>
  <keyword>Japan</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Arrest</mesh_term>
    <mesh_term>Hypothermia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

